CORCEPT THERAPEUTICS INC Operating Leases, Rent Expense
CORCEPT THERAPEUTICS INC (CORT) reported Operating Leases, Rent Expense of $1.30 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-02-23
- CORCEPT THERAPEUTICS INC operating leases, rent expense for the quarter ending 2018-12-31 was $400.00K, a 33.33% increase year-over-year.
- CORCEPT THERAPEUTICS INC operating leases, rent expense for the quarter ending 2018-09-30 was $300.00K, a 0.00% change year-over-year.
- CORCEPT THERAPEUTICS INC operating leases, rent expense for the quarter ending 2018-06-30 was $300.00K, a 0.00% change year-over-year.
- CORCEPT THERAPEUTICS INC operating leases, rent expense for the quarter ending 2018-03-31 was $300.00K, a 0.00% change year-over-year.
- CORCEPT THERAPEUTICS INC operating leases, rent expense for fiscal 2018 was $1.30M, a 18.18% increase from fiscal 2017.
- CORCEPT THERAPEUTICS INC operating leases, rent expense for fiscal 2017 was $1.10M, a 22.22% increase from fiscal 2016.
- CORCEPT THERAPEUTICS INC operating leases, rent expense for fiscal 2016 was $900.00K, a 28.57% increase from fiscal 2015.
- CORCEPT THERAPEUTICS INC operating leases, rent expense for fiscal 2015 was $700.00K, a 14.94% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 3 month as first filed | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 6 month as first filed | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 9 month as first filed | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $700.00K derived: sum of 2 quarters · filed 2021-02-23 | $1.00M derived: sum of 3 quarters · filed 2021-02-23 | $1.30M 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | $300.00K 10-Q · filed 2018-11-02 | $600.00K derived: sum of 2 quarters · filed 2018-11-02 | $900.00K 10-Q · filed 2018-11-02 | $1.20M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $300.00K 10-Q · filed 2018-08-09 | $600.00K 10-Q · filed 2018-08-09 | $900.00K derived: sum of 3 quarters · filed 2020-02-24 | $1.20M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $300.00K 10-Q · filed 2018-05-09 | $600.00K derived: sum of 2 quarters · filed 2020-02-24 | $900.00K derived: sum of 3 quarters · filed 2020-02-24 | $1.20M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $600.00K derived: sum of 2 quarters · filed 2020-02-24 | $900.00K derived: sum of 3 quarters · filed 2020-02-24 | $1.10M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $300.00K 10-Q · filed 2018-11-02 | $279.00K 10-Q · filed 2017-11-03 | $600.00K derived: sum of 2 quarters · filed 2018-11-02 | $800.00K 10-Q · filed 2018-11-02 | $786.00K 10-Q · filed 2017-11-03 | $1.16M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-06-30 | $300.00K 10-Q · filed 2018-08-09 | $256.00K 10-Q · filed 2017-08-02 | $500.00K 10-Q · filed 2018-08-09 | $507.00K 10-Q · filed 2017-08-02 | $861.00K derived: sum of 3 quarters · filed 2019-02-26 | $1.11M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-03-31 | $300.00K 10-Q · filed 2018-05-09 | $251.00K 10-Q · filed 2017-05-02 | $561.00K derived: sum of 2 quarters · filed 2019-02-26 | $807.00K derived: sum of 3 quarters · filed 2019-02-26 | $1.02M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $507.00K derived: sum of 2 quarters · filed 2019-02-26 | $725.00K derived: sum of 3 quarters · filed 2019-02-26 | $900.00K 10-K · filed 2019-02-26 | $885.00K 10-K · filed 2017-03-06 | |||
| 2016-09-30 | $246.00K 10-Q · filed 2017-11-03 | $464.00K derived: sum of 2 quarters · filed 2017-11-03 | $639.00K 10-Q · filed 2017-11-03 | $866.00K derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-06-30 | $218.00K 10-Q · filed 2017-08-02 | $394.00K 10-Q · filed 2017-08-02 | $620.00K derived: sum of 3 quarters · filed 2018-02-28 | $778.00K derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-03-31 | $176.00K 10-Q · filed 2017-05-02 | $402.00K derived: sum of 2 quarters · filed 2018-02-28 | $560.00K derived: sum of 3 quarters · filed 2018-02-28 | |||||
| 2015-12-31 | $226.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $384.00K derived: sum of 2 quarters · filed 2018-02-28 | $700.00K 10-K · filed 2018-02-28 | $678.00K 10-K · filed 2016-03-10 | ||||
| 2015-09-30 | $158.00K 10-Q · filed 2016-11-02 | $474.00K 10-Q · filed 2016-11-02 | ||||||
| 2014-12-31 | $609.00K 10-K · filed 2017-03-06 | |||||||
| 2013-12-31 | $428.00K 10-K · filed 2016-03-10 | |||||||
| 2012-12-31 | $360.00K 10-K · filed 2015-03-13 | |||||||
| 2011-12-31 | $285.00K 10-K · filed 2014-03-14 | |||||||
| 2010-12-31 | $250.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |